The Pim kinases: New targets for drug development

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Drug Development 100%
• Carcinogenesis 50%
• Epileptic Absence 50%
• Adenocarcinoma 50%
• Aciclovir 50%
• Adenosine Triphosphate 50%
• Solid Malignant Neoplasm 50%
• Protein Serine Threonine Kinase 50%
• Leukemia 50%
• Protein Tyrosine Kinase 50%
• Rapamycin 50%
• Myeloma 50%
• Janus Kinase 2 50%
• Mammalian Target of Rapamycin Inhibitor 50%
• Moloney Murine Leukemia Virus 50%

Keyphrases

• Viral Integration Sites 14%